About Sumayah Jamal
Form D filings for ENB Therapeutics from 2018 to 2023 list Sumayah Jamal as executive officer and director.
Sumayah Jamal first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Sumayah Jamal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sumayah Jamal works with at each company, as listed on that company's latest Form D.
ENB Therapeutics, Inc. · Form D, Oct 3, 2023